TALKDESK
Talkdesk®, Inc., a global AI-powered contact center leader for enterprises of all sizes, today announced its presence at the All4Customer event in Paris from March 26 - 28, 2024. Investment in the event is part of the company’s commitment to the French market and to driving exceptional outcomes for customers and partners across the region with the power of artificial intelligence (AI)-driven customer experience.
Simon Desvergez, enterprise solutions engineer at Talkdesk, will deliver a masterclass on supercharging contact center optimization with generative AI (GenAI) on Wednesday, March 27, 2024 at 12:00 p.m. in Masterclass 6. During the 45-minute session, industry professionals will hear examples of how GenAI has automated complex customer use cases and significantly improved the quality of self-service interactions.
The All4Customer event, which attracts approximately 15,000 attendees, is the latest example of continued commitment from Talkdesk to the French market. Over the past several months, Talkdesk has exhibited at the Customer Relationship and Marketing Meetings (CRM&M) event in Cannes to gain opportunities to meet face-to-face with local customer experience (CX) leaders and held the Talkdesk Partner Academy in Paris as an investment in its partner ecosystem.
Tiago Paiva, founder and chief executive officer at Talkdesk, commented: “France continues to be a significant business driver for the company, and we’re excited for 2024 to drive further local expansion for Talkdesk. All4Customer is an important opportunity for us to connect with local CX leaders in-person and discuss the value that deploying AI cloud technology can unlock in the contact center.”
Customers such as Quadient, a global leader in cloud-based business communication software, parcel locker solutions, and mailing systems technology based in Bagneux, France, uses Talkdesk to deliver frictionless customer interactions. Before implementing Talkdesk, 40% of Quadient’s call volume in some queues consisted of simple transactions that could be self-serviced to reserve agents’ time for more complex tasks. Quadient initially developed its self-service solutions with Talkdesk, then expanded to other Talkdesk tools, including a solution to assist with agent coaching and a voice bot. As a result, Quadient doubled its self-service capabilities, increased efficiency, and created better experiences for customers and agents.
Jackie James, director of global operations at Quadient, said: “The thing that I like about Talkdesk more than anything is that they're constantly looking for ways to improve. They’re regularly deploying features that have positive impacts on CX." As one example of this, James added: “By using a voice bot [to serve Parcel Pending], we could contain a lot of simple transactions just by walking the customer through a few steps and using some integrations with our web application. We immediately saw a 60% containment rate.”
FACYLE, a key partner of Talkdesk in the French market specializing in Consulting and CTI integration, expressed excitement about the ongoing collaboration. As a crucial launch partner, FACYLE has significantly contributed to the success of Talkdesk in France. FACYLE Chief Executive Officer Francois Breuiller highlighted the consistent investment from Talkdesk in the success of their partnership and the French market.
The Talkdesk-FACYLE partnership has led to notable achievements, including successful projects with Groupe APRIL and Groupe Monnoyeur. This success is attributed to dedication from Talkdesk in providing resources, materials, and events tailored for the French audience. These efforts have accelerated momentum, empowering enterprises to enhance customer experiences through the Talkdesk AI-powered contact center solutions.
Francois Breuiller further emphasized the positive impact of the partnership, stating: "Partnering with Talkdesk for the past two years has proven that we made the right choice for a pure CCaaS solution. We successfully implemented their solution on large customers’ projects, showcasing robustness and comprehensive feature coverage.”
The All4Customer event will take place at Paris Expo Porte de Versailles, Pavilion 4, where Talkdesk will exhibit in stand F28. For more information, visit www.all4customer-paris.com.
About Talkdesk
Talkdesk® is a global cloud contact center leader for enterprises of all sizes. Talkdesk CX Cloud and Industry Experience Clouds help enterprises deliver modern customer service their way. Our trusted, flexible, and innovative contact center platform leverages AI and automation to drive exceptional outcomes for their customers and improve the bottom line. Serving enterprise customers in over 100 countries, we partner with our customers to deliver continuous innovation and breakthrough results. Our unwavering commitment to doing what we say we will do and our investment in the highest levels of security and reliability for our products make us second to none in the industry. Improve customer experiences, increase efficiency, and grow revenue with Talkdesk, a cloud contact center platform built for your industry. Learn more and take a self-guided demo at www.talkdesk.com.
Talkdesk is a registered trademark of Talkdesk, Inc. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240125676968/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom